Mats Lindblad

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden
    Mats Lindblad
    Department of Surgical Sciences, Karolinska University Hospital, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 13:2203-7. 2004
  2. pmc Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
    L A Garcia Rodriguez
    Department of Surgery, P9 03, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Gut 55:1538-44. 2006
  3. pmc Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
    M Lindblad
    Unit of Oesophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Br J Cancer 94:136-41. 2006
  4. ncbi request reprint Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study
    Mats Lindblad
    Department of Surgical Sciences, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Cancer Causes Control 16:285-94. 2005
  5. ncbi request reprint Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
    Mats Lindblad
    Department of Surgery, P9 03, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 14:444-50. 2005
  6. doi request reprint Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma
    Evangelos Chandanos
    Unit of Esophageal and Gastric Research, Section of Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Gastric Cancer 11:168-74. 2008
  7. ncbi request reprint Impact of hospital volume on long-term survival after esophageal cancer surgery
    Ioannis Rouvelas
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Arch Surg 142:113-7; discussion 118. 2007
  8. ncbi request reprint Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study
    Ioannis Rouvelas
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    World J Surg 30:2182-90; discussion 2191-2. 2006
  9. pmc Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden
    Pernilla Viklund
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Ann Surg 243:204-11. 2006
  10. doi request reprint Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study
    Rickard Ljung
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    J Clin Psychopharmacol 32:336-40. 2012

Detail Information

Publications31

  1. ncbi request reprint Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden
    Mats Lindblad
    Department of Surgical Sciences, Karolinska University Hospital, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 13:2203-7. 2004
    ..The global pattern of male predominance in gastric cancer incidence remains unexplained. We tested the hypothesis that estrogen prevents gastric cancer in a cohort of men heavily exposed to estrogen...
  2. pmc Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
    L A Garcia Rodriguez
    Department of Surgery, P9 03, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Gut 55:1538-44. 2006
    ..Gastric acid suppressing drugs (that is, histamine(2) receptor antagonists and proton pump inhibitors) could affect the risk of oesophageal or gastric adenocarcinoma but few studies are available...
  3. pmc Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
    M Lindblad
    Unit of Oesophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Br J Cancer 94:136-41. 2006
    ..34, 95% CI 0.14-0.78) and weaker for gastric cardia tumours (OR 0.68, 95% CI 0.23-2.01). There was no association between HRT and oesophageal adenocarcinoma (OR 1.17, 95% CI 0.41-3.32)...
  4. ncbi request reprint Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study
    Mats Lindblad
    Department of Surgical Sciences, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Cancer Causes Control 16:285-94. 2005
    ....
  5. ncbi request reprint Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
    Mats Lindblad
    Department of Surgery, P9 03, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 14:444-50. 2005
    ..Nonsteroidal anti-inflammatory drugs (NSAID) might reduce risks of esophageal and gastric cancer, but previous studies are limited and provide somewhat conflicting results...
  6. doi request reprint Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma
    Evangelos Chandanos
    Unit of Esophageal and Gastric Research, Section of Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Gastric Cancer 11:168-74. 2008
    ..Estrogen might protect women against gastric adenocarcinoma of the intestinal histological type. We addressed this hypothesis and proposed that gastric estrogen receptors (ERs) are involved...
  7. ncbi request reprint Impact of hospital volume on long-term survival after esophageal cancer surgery
    Ioannis Rouvelas
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Arch Surg 142:113-7; discussion 118. 2007
    ..The improved survival after esophageal cancer surgery in Sweden during recent years may be attributable to the increased centralization of such surgery...
  8. ncbi request reprint Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study
    Ioannis Rouvelas
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    World J Surg 30:2182-90; discussion 2191-2. 2006
    ..The aim of this study was to assess the surgical outcomes with and without neoadjuvant treatment for resectable esophageal cancer in a population-based setting...
  9. pmc Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden
    Pernilla Viklund
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Ann Surg 243:204-11. 2006
    ..To identify risk factors for complications after resection for esophageal or cardia cancer...
  10. doi request reprint Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study
    Rickard Ljung
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    J Clin Psychopharmacol 32:336-40. 2012
    ..0 (95% CI, 0.9-1.1). The OR for antidepressant use other than SSRI showed a similar pattern. In conclusion, no increased risk of acute pancreatitis remained among users of SSRI after adjusting for confounding factors...
  11. pmc Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates
    Mats Lindblad
    Department of Surgical Sciences, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
    Ann Surg 243:479-85. 2006
    ..To evaluate the diagnostic accuracy of esophageal and cardia adenocarcinoma in the Swedish Cancer Register...
  12. ncbi request reprint Quality of life and persisting symptoms after oesophageal cancer surgery
    Pernilla Viklund
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery P9 03, Karolinska Institutet, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Eur J Cancer 42:1407-14. 2006
    ..Thus, patients who undergo oesophageal cancer resection suffer greatly from reduced QoL and several general and oesophageal-specific symptoms six months postoperatively...
  13. doi request reprint Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study
    Omid Sadr-Azodi
    Unit of Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Norra Stationsgatan 67, SE 171 76 Stockholm, Sweden
    JAMA Intern Med 173:444-9. 2013
    ..Oral glucocorticoid use has been suggested to cause acute pancreatitis in several case reports. However, no epidemiological study has investigated this association...
  14. ncbi request reprint Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study
    Tomas Sjöberg
    Unit of Esophageal and Gastric Research, Karolinska Institutet, Stockholm, Sweden
    Clin Gastroenterol Hepatol 5:1160-1166.e1. 2007
    ..There are contradictory results regarding the association between angiotensin-converting enzyme (ACE) inhibitors and cancer. We aimed to investigate whether ACE inhibitors protect against esophageal and gastric cancer...
  15. doi request reprint Tamoxifen exposure in relation to gastric adenocarcinoma development
    Evangelos Chandanos
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Eur J Cancer 44:1007-14. 2008
    ....
  16. doi request reprint Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study
    Rickard Ljung
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Norra Stationsgatan 67, 2nd Floor, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Gut 61:873-6. 2012
    ..To evaluate the suggested association between tetracycline and acute pancreatitis in a large pharmacoepidemiological study...
  17. ncbi request reprint Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection
    Pernilla Viklund
    Department of Surgical Science, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden
    World J Surg 29:841-8. 2005
    ..In conclusion, any measures that can reduce the risk of major surgery-related complications can decrease the negative impact on quality of life after esophageal cancer surgery. More population-based studies are warranted, however...
  18. ncbi request reprint Survival after surgery for oesophageal cancer: a population-based study
    Ioannis Rouvelas
    Unit of Oesophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Lancet Oncol 6:864-70. 2005
    ..However, few population-based studies of survival after surgery have been done. We aimed to assess whether survival after surgery for oesophageal cancer has improved since 1987...
  19. pmc Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden
    E Chandanos
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Br J Cancer 95:118-22. 2006
    ..We concluded that there might be a link between tamoxifen and risk of non-cardia gastric adenocarcinoma...
  20. doi request reprint Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006
    Martin Rutegård
    Upper GastroIntestinal Research UGIR, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Eur J Cancer 46:1093-100. 2010
    ..An endogenous factor, such as premenopausal oestrogen exposure, may act protectively in favour of women and might be detected by scrutinising sex ratios and incidence rates stratified by age...
  21. doi request reprint Reliability of acute pancreatitis diagnosis coding in a National Patient Register: a validation study in Sweden
    Dan Razavi
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Pancreatology 11:525-32. 2011
    ..The main aim of this study was to validate the diagnosis coding for acute pancreatitis in the Swedish National Patient Register...
  22. doi request reprint Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study
    Tomas Sjöberg Bexelius
    Department of Molecular Medicine and Surgery, Unit of Esophageal and Gastric Research ESOGAR, Karolinska Institutet, Solna, Stockholm, Sweden
    Pancreatology 9:786-92. 2009
    ..There is no specific treatment against acute pancreatitis (AP). A protective effect by angiotensin II receptor blockers (ARB) on AP has been suggested experimentally, but clinical evidence is scarce...
  23. ncbi request reprint The influence of needle catheter jejunostomy on weight development after oesophageal cancer surgery in a population-based study
    L Martin
    Unit of Esophageal and Gastric Research ESOGAR, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Eur J Surg Oncol 33:713-7. 2007
    ..We aimed to assess whether needle catheter jejunostomy (NCJ) influences the weight development or discharge from hospital after oesophageal cancer surgery in an unselected and prospectively collected series of patients...
  24. ncbi request reprint Malnutrition after oesophageal cancer surgery in Sweden
    L Martin
    Unit of Esophageal and Gastric Research ESOGAR, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Br J Surg 94:1496-500. 2007
    ..The aim of this study was to estimate weight change after surgery in a population-based setting and to identify nutritional problems that might correlate with weight loss...
  25. ncbi request reprint Further studies on serrated neoplasias of the cardia: a review and case report
    Carlos A Rubio
    Department of Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden
    Anticancer Res 27:4431-4. 2007
    ..Serrated adenomas of the cardia seem to have a particular proclivity to evolve into invasive carcinomas...
  26. ncbi request reprint No association between gastroesophageal reflux and cancers of the larynx and pharynx
    Magnus Nilsson
    Department of Surgery P9 03, Karolinska Hospital, SE 171 76 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 14:1194-7. 2005
    ..To examine the proposed relation between gastroesophageal reflux disease and cancers of the larynx and pharynx...
  27. doi request reprint Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection
    M Rutegård
    Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Br J Surg 95:592-601. 2008
    ..This study explored how selected surgical factors affected HRQL 6 months after operation...
  28. ncbi request reprint Surgeon volume and postoperative mortality after oesophagectomy for cancer
    I Rouvelas
    Unit of Oesophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, SE 171 76 Stockholm, Sweden
    Eur J Surg Oncol 33:162-8. 2007
    ..Our aim was to assess the association between surgeon volume and postoperative mortality after oesophagectomy...
  29. pmc Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial
    Tomas Sjöberg Bexelius
    Tomas Sjöberg Bexelius, John Blomberg, Yun Xia Lu, Jesper Lagergren, Mats Lindblad, Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 176 70 Stockholm, Sweden
    World J Gastrointest Endosc 4:506-12. 2012
    ..To study if the angiotensin II receptor blockers (ARB) losartan counteracts pancreatic hyperenzymemia as measured 24 h after endoscopic retrograde cholangiopancreatography (ERCP)...
  30. doi request reprint Risk factors and chemoprevention in Barrett's esophagus--an update
    Hanna Winberg
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Upper GastroIntestinal Research UGIR, Stockholm, Sweden
    Scand J Gastroenterol 47:397-406. 2012
    ..Additionally, we summarize today's status on the use of chemoprevention aiming to reduce the risk of cancer progression in BO patients...
  31. ncbi request reprint Quantitative risk assessment of thermophilic Campylobacter spp. and cross-contamination during handling of raw broiler chickens evaluating strategies at the producer level to reduce human campylobacteriosis in Sweden
    Roland Lindqvist
    National Food Administration, P O Box 622, S 751 26 Uppsala, Sweden
    Int J Food Microbiol 121:41-52. 2008
    ..However, any improvements following implementation of these strategies may be hard to detect if less than 50% of reported cases are exposed via chicken and the cross-contamination route...